Wang H, Ananthapadmanabhan S, Rahkala J, et al. A review of prostate cancer focal therapies in general practice. Aust J Gen Pract 2025;54(9):654–58. Available at www1. racgp.org.au/ajgp
In this article, references and citations have been corrected and extensively changed.
- Reference 7 was Wilt TJ, Jones KM, Barry MJ, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med 2017;377(2):132–42. doi: 10.1056/NEJMoa1615869. This has been changed to Stamey TA, McNeal JM, Wise AM, Clayton JL. Secondary cancers in the prostate do not determine PSA biochemical failure in untreated men undergoing radical retropubic prostatectomy. Eur Urol 2001;39(Suppl 4):22–3. doi: 10.1159/000052577.
- References 13–15 were listed in the incorrect order and have now been corrected. Reference 21 was incorrectly referenced and has been removed; all remaining references have been renumbered accordingly.
- Reference 21 was incorrectly referenced and has been removed; all remaining references have been renumbered accordingly.
Table 1 was titled: Focal therapies versus whole-gland treatments: Reported incidence of side effects. This has been changed to: Focal therapies versus whole-gland treatments: A summary of the incidence of side effects.